Alexza Pharmaceuticals is focused on the acute treatment of central nervous system conditions. Alexa’s lead program, ADASUVE, New Drug Application has a PDUFA goal date of December 21, 2012.
Going forward ... (see research report)
Copyright ® 2016. The Bedford Report. All Rights Reserved.